stockrowEvolus, Inc. (EOLS) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Evolus, Inc. EOLS 6.84 +0.59%
- Ironwood Pharmaceuticals, Inc. IRWD 4.39 +8.93%
Evolus, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $665.9M against $448.8M — 1.5× the size. Evolus, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.3×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 18.1% against 13.9%. Ironwood Pharmaceuticals, Inc. has the higher net margin (37.4% vs −9.56%) and the higher return on invested capital (0.00% vs −12.6%). Across the 18 metrics below, Ironwood Pharmaceuticals, Inc. leads on 11 and Evolus, Inc. on 7.
Valuation
Profitability
| Metric | EOLS | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.38% | 100.00% | 53.51% |
| Operating margin | (4.79%) | 62.91% | 0.00% |
| Net margin | (9.56%) | 37.38% | (2.45%) |
| Free cash flow margin | (2.71%) | 51.31% | 0.00% |
| Return on equity | 93.47% | (82.81%) | (0.80%) |
| Return on assets | (12.38%) | 43.58% | (1.67%) |
| Return on invested capital | (12.60%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack